Abstract Susceptibility to a series of autoimmune diseases is strongly associated with particular HLA class II alleles. Identification of T cell clones and antigenic epitopes bound by HLA class II molecules involved in autoimmune diseases is critical to understanding the etiology of these HLA class II-associated diseases. However, establishment of T cell clones in autoimmune diseases is difficult because the antigenic peptides are unknown. Peptide library methods which include all possible peptide sequences offer a potentially powerful tool for the detection of cross-reactive antigenic peptides recognized by T cells. Here, we reduced the number of peptides per mixture by utilizing the known binding motifs of peptides for the HLA-DRB1*0405 molecule and evaluated the effectiveness of this library design. Each library mixture evoked a strong proliferative response in the unprimed peripheral blood lymphocytes (PBL) from HLA-DRB1*0405-positive donors but little or no response in the PBL from HLA-DRB1*0405-negative donors. The library also detected antigenic peptides that activated three antigen-specific T cell lines restricted by HLA-DRB1*0405, with different specificities. The motif-based approach thus presents a powerful method for monitoring T cells in large, heterogeneous T cell populations and is useful for the identification of the mimic peptide epitopes of T cell lines and clones.
Introduction
A great deal of progress has been made in identifying statistical associations between HLA and autoimmune diseases (Tiwari and Terasaki 1985; Dong et al. 1993; Yasunaga et al. 1996; Thorsby 1997) . There are at least two possible mechanisms for observed associations. One is a direct involvement of HLA genes in the pathogenesis of associated diseases, and another is the effects of other genes which are in strong linkage disequilibrium with the associated HLA loci. Primary involvement of HLA molecules in HLA-associated diseases may be a result of preferential binding and presentation to potential autoreactive T cells of peptides derived from autoantigens, by the HLA molecule associated with the disease. As previously reported, many of these diseases are associated with HLA molecules that share particular pockets in their peptide-binding clefts, which may play a decisive role in determining which autoantigen-derived peptides may be bound (Hammer et al. 1995; Thorsby 1997) . The identification of these etiologic peptides seems to be essential for investigations into immune dysfunction and autoimmune disease. Knowledge of epitopes involved in immunological disorders may facilitate therapeutic or prophylactic intervention. However, little is known about the characteristics of the autoimmune epitope peptides bound to specific HLA molecules that are associated with susceptibility to these diseases, because of the difficulty in generating T cell clones without knowledge of antigens.
Peptide library methods offer a potentially powerful tool for the detection of antigenic peptides recognized by T cells. To date, two major approaches to peptide library design using combinatorial chemistry have been successful in the identification of T cell antigenic peptides. One such design utilized two fixed amino acid residues of peptide at the binding anchors of an HLA class I molecule, and randomized seven other positions in a mixture. This library was used to detect mimics of tumor epitope recognized by MHC class I restricted cytotoxic T lymphocytes (CTL) (Blake et al. 1996) . Another approach to peptide libraries is a "comprehensive" design in which all potential peptides of a given length are included in a peptide mixture. This approach was successfully employed in the identification of an epitope mimic recognized by a myelin basic protein (MBP)-specific, MHC class II restricted, autoreactive T cell clone in humans (Hemmer et al. 1997) , and an alloreactive, MHC class I restricted T cell clone in mice (Udaka et al. 1995 (Udaka et al. , 1996 .
The peptide mixtures of a "comprehensive" library result in designs with more than 20 9 peptide species per peptide mixture. However, the possible number of peptide species in a mixture that can be detected by T cells is limited by the total number of HLA molecules present in the screening system, because T cells respond to peptides only in the context of HLA molecules. The number of MHC molecules on an individual antigen-presenting cell has been estimated to be 10 5 on average (Demotz et al. 1990; Harding and Unanue 1990; Christinck et al. 1991) . The minimum number of same-species MHC/peptide complexes required for the activation of murine T cell clones has been estimated at 10 2 complexes per cell (Demotz et al. 1990; Harding and Unanue 1990; Christinck et al. 1991) . If the number of peptide species in a mixture exceeds this limit, certain of the peptide species which have relatively higher affinity to a specific MHC molecule in the mixture would bind the MHC molecule while other peptide species would remain in suspension and would be undetected, and therefore unscreened by T cells.
The HLA-DRB1*0405 molecule is one of the most frequent alleles in the Japanese population, and is associated with several autoimmune diseases including rheumatoid arthritis (Tsuchiya et al. 1992) . In this report, by assigning fixed amino acid residues appropriate for the binding motif for the HLA-DRB1*0405 molecule at the four MHC anchor residues for this molecule, and by assigning fixed amino acid residues at two of six possible T cell receptor (TCR) contact positions, we created a combinatorial motifaided peptide epitope library (MAPEL). To evaluate the effectiveness of this design, we examined the proliferative response of peripheral blood lymphocytes (PBL) from HLA-DRB1*0405-positive donors and HLA-DRB1*0405-negative donors, and antigen-specific T cell lines and T cell clones from HLA-DRB1*0405-positive donors, to the MAPEL.
Materials and methods

Peptide synthesis
Peptides were synthesized on a 396MPS multiple peptide synthesizer (Advanced Chem Tech, Louisville, KY, USA), using standard F-moc amino acids with N,N′-Diisopropylcarbodiimide/1-Hydroxy-1H-benzotriazole monohydrate (DIC/HOBt) coupling chemistry on a polystyrene resin. Combinatorial peptide libraries were synthesized using a solid phase 'split synthesis' of nine peptide mixtures containing either X (T, L, K, Q, D, M, F, H, V) or Z (S, I, R, N, E, C, Y, P, W) group amino acids with a standard F-moc chemistry as previously reported (Lam et al. 1991; Houghten et al. 1991) . After each coupling step of mixture position, the beads from each of the nine reaction vessels were combined for randomization and then split again to nine vessels for the next coupling step. After three such iterations, the 729 (9 3 ) peptide sequences were synthesized. Peptides were cleaved from the resin with trifluoroacetic acid (TFA) containing 1% ethanedithiol, 3% anisole, and 3% ethylmethylsulfide. The cleaved peptides were washed with diethyl ether, and frozen dry in 10% acetic acid. The quality of the cleaved peptides was monitored by reversephase HPLC (gradient from 0.1% TFA in water to 0.1% TFA in acetonitrile, UV detection at 214␣ nm) using a C18 column (Millipore, Milford, MA, USA) and by electrospray mass spectrometry. The amino acid composition in the randomized sequence positions of the library was determined by pool sequencing. Peptides were dissolved in autoclaved double-distilled H 2 O at 1␣ mM and stored at -20°C. The amino acid residues are usually referred to by the one-letter amino acid code, and sometimes by the full-letter code.
HLA DNA typing DNA was extracted from the peripheral granulocytes of each subject following the protocol of the 11th International Histocompatibility Workshop . HLA class II genes (DRB1, DRB3, DRB4, DRB5, DQA1, DQB1, DPA1, DPB1) were determined by polymerase chain reaction/oligonucleotide probes (PCR/SSOP) analysis, as described previously .
Generation of T cell lines
A purified protein derivative (PPD)-specific T cell line was generated as previously reported (Dong et al. 1995 
Transfectant
HLA class II DR4 (DRA*0102/DRB1*0405) α and genes were cotransfected with PAG60 harboring a neomycinresistant gene into a mouse L fibroblast cell line as described previously (L-DR4) (Kamikawaji et al. 1991) .
T cell proliferation assay PBL were separated by using a density gradient centrifugation method. PBL (1 ϫ 10 5 ) were cultured in each well of a round-bottomed 96-well microtiter plate (Corning, NY, USA) in 200␣ µl RPMI 1640 medium(Life Technologies, Grand Island, NY, USA) supplemented with 10% pooled male human serum (HS), 2␣ mM L-glutamine (Life Technologies), and 100␣ U/ml penicillin-100␣ µg/ml streptomycin (Life Technologies), with 50␣ µM HLA-DRB1*0405 MAPEL. Cells were cultured at 37°C with 5% CO 2 in a humidified atmosphere for 6 days and pulsed with 1␣ µCi of 3 H-thymidine (ICN Biomedicals, Casta Mesa, CA, USA). Cells were harvested on glass fiber filters (Wallac, Turku, finland) after an additional 18-h culture, and incorporated radioactivity was measured by a liquid scintillation counter (Wallac). Results were expressed as the mean counts per minute (cpm) of five well cultures.
Antigen-specific proliferation of the T cell line was assayed by culturing the cells (4 ϫ 10 4 /well) in 96-well flatbottom culture plates in the presence or absence of synthetic peptide using mitomycin C treated L-DR4 (3.5 ϫ 10 4 /well) in a total volume of 200␣ µl, as described (Kamikawaji et al. 1991) . Cells were cultured for 72␣ h in the presence of 1␣ µCi/well of 3 H-thymidine for the last 12␣ h. Cells were harvested on glass fiber filters (Wallac, Turku, finland), and the incorporated radioactivity was measured by a liquid scintillation counter (Wallac). Results were expressed as the mean cpm of duplicate cultures.
Results
Design strategy for the HLA-DRB1*0405 motif-aided peptide epitope library A binding motif for HLA-DRB1*0405-associated peptides has been elucidated by several investigators from analysis of endogenous peptides eluted from the molecule (Kinouchi et al. 1994; Matsushita et al. 1994; Rammensee et al. 1995; Friede et al. 1996) . The motif is composed of nine amino acid residues of which position 1, 4, 6, and 9 (P1, P4, P6, and P9) are considered to be anchor positions as shown in Table␣ 1. We have identified three antigenic peptides presented by the HLA-DRB1*0405 molecule. These peptides were derived from streptococcal M12 protein, Cryptomeria japonica pollen antigen 1 (Cry j 1), or Cryptomeria japonica pollen antigen 2 (Cry j 2) (Table␣ 2). M12 peptide 347-367 was previously reported to be an antigenic peptide recognized by M12-specific and HLA-DRB1*0405-restricted T cell lines (Dong et al. 1995) . According to alanine substitution analysis and truncated peptide analysis, a nine amino acid peptide, M12 355-363, was demonstrated to be the core antigenic peptide recognized by the T cell line. This peptide fits the binding motif 
Bold represents putative anchor points.
for HLA-DRB1*0405␣ at P1 leucine, P4 leucine, and P9 aspartic acid. Within the 20 mer peptide of Cry j 1 (Hori et al. 1996) , which was recognized by a Cry j 1-specific, HLA-DRB1*0405-restricted T cell line, Cry j 1 235-254 fit the binding motif at P1 valine, P6 asparagine, and P9 aspartic acid. Similarly, within the 20 mer peptide of Cry j 2 (Hori et al. 1996) , which was recognized by a Cry j 2-specific, HLA-DRB1*0405-restricted T cell line, Cry j 2 145-164 fit the binding motif at P1 phenylalanine, P4 valine, and P9 glutamic acid. It was reported that substitutions among residues permissive for HLA binding at the HLA anchor sites have relatively little effect on T cell activity compared with alterations at TCR contact residues (Suhrbier et al. 1991; Reay et al. 1994; Kuchroo et al. 1994 ). Thus, we assigned a single, fixed, binding-permissive residue at each of these anchor residue positions, P1Y, P4L, P6A, and P9D. The remaining positions, P2, P3, P5, P7, and P8, were considered to be putative TCR contact positions. In addition, the amino acid at P0 (on the N terminal side of the first anchor residue P1) was previously suggested to be a critical residue in the activation of myelin basic protein (MBP)-specific T cell clones . Including this position (P0), we assigned six positions as putative TCR contact sites (P0, P2, P3, P5, P7, and P8). Among the putative TCR contact residues, not all residues are simultaneously critical for recognition by cloned T cells, and substitution by certain other amino acids at noncritical positions also has relatively little adverse effect on T cell activity (Kuchroo et al. 1994; Evavold et al. 1992; Kersh and Allen 1996) . We assigned a fixed, unobtrusive amino acid alanine to two of these six positions, and randomized the remaining four positions, giving 15 combinations of 4-site randomizations (6C4 = 15) for putative TCR contact residues. We divided 18 amino acids into two groups, X (T, L, K, Q, D, M, F, H, V) and Z (S, I, R, N, E, C, Y, P, W), and placed either X or Z at each of the four putative TCR contact positions. Thus, we developed 15 sets of heterogeneous peptide mixtures grouped according to the nine different amino acids of either the X or Z group at the putative T cell contact residue closest to the N terminal end (P0, P2, or P3), with the other three putative T cell contact positions randomized among the nine X or Z group amino acids. N-terminal K, E and C-terminal A, E, K were added to all peptides to increase solubility and to stabilize the MHC/ peptide/ TCR interactions (Fig.␣ 1) .
PBL proliferation induced by the HLA-DRB1*0405 MAPEL We examined the proliferative responses of unstimulated PBL to the MAPEL peptide mixtures. PBL from an HLA-DRB1*0405 homozygote were cultured with each of 135 heterogeneous peptide mixtures of the HLA-DRB1*0405 MAPEL for 1 week and the proliferative responses were measured by 3 H-thymidine uptake assays. In fig.␣ 1, 135 peptide mixtures of the HLA-DRB1*0405 MAPEL are shown; of these, 19% (25 mixtures) induced strong proliferation of PBL (>45,000␣ cpm), 43% (58 mixtures) induced moderate proliferation (>15,000␣ cpm, <45,000␣ cpm), and 38% (52 mixtures) induced weak proliferation (<15,000␣ cpm). Thus, all peptide mixtures had the ability to induce some T cell proliferation without prior immunization. Furthermore, blocking experiments using anti-HLA-DR monoclonal antibodies (mAbs;HU-4) confirmed that this proliferation was HLA-DRBI*0405 restricted (data not shown).
We further studied the proliferative responses of unstimulated PBL from six healthy adults (three HLA-DRB1*0405-positive donors, three HLA-DRB1*0405-negative donors) to 63 mixtures (Fig.␣ 2) . Over half of the 63 peptide mixtures induced moderate or strong proliferation (>15,000␣ cpm) of PBL from HLA-DRB1*0405-positive donors. In contrast, most of the 63 peptide mixtures induced only weak proliferation (<15,000␣ cpm) of PBL from HLA-DRB1*0405-negative donors, indicating that the library was indeed optimized for the binding motif of HLA-DRB1*0405. In addition, there were close correlations in the proliferative response patterns to the MAPEL among the three HLA-DRB1*0405 heterozygotes. The correlation coefficients between individuals were 0.73 between NK and HA, 0.71 between NK and SN, and 0.62 between HA and SN. These correlations were well over 0.32, the criterion for statistical significance of 1%. The proliferation of PBL in seven additional HLA-DRB1*0405-positive donors was further examined. The average of the correlation coefficients among 10 donors was 0.53 (data not shown). Thus, the HLA-DRB1*0405 MAPEL can induce proliferation of PBL from HLA-DRB1*0405-positive adult donors more effectively and specifically than in PBL from HLA-DRB1*0405-negative adult donors, and PBL from HLA-DRB1*0405-positive adult donors have highly similar response characteristics to the peptide mixtures of the HLA-DRB1*0101-motif-oriented peptide mixtures and HLA-DRB1*0901-motif-oriented peptide mixtures, both of which were composed of nine sets of peptide mixtures. In these mixtures, we assigned a single, fixed, binding-permissive residue at each of the anchor residue positions, P1Y, P4L, P6A, and P9L for HLA-DRB1*0101-motif-oriented peptide mixtures, and P1Y, P4␣ S, P6A, and P9A for HLA-DRB1*0901-motif-oriented peptide mixtures, based on information from eluted peptides from HLA-DRB1*0101 and HLA-DRB1*0901 (Rammensee et al. 1995; Futaki et al. 1995) . At the TCR contact sites, the sequence combinations which induced the strongest PBL proliferation by HLA-DRB1*0405-positive donors in the case of HLA-DRB1*0405 MAPEL were used. In the HLA-DRB1*0101-motif-oriented peptide mixtures, only the P9 position was different from the corresponding HLA-DRB1*0405 mixture. For the HLA-DRB1*0901-motif-oriented peptide mixtures, P4 and P9 position residues were different from those with HLA-DRB1*0405-oriented motifs.
We examined the proliferation of PBL in an HLA-DRB1*0405 homozygote and an HLA-DRB1*0101 homozygote to the nine sets of peptide mixtures for both alleles (Fig.␣ 3a) . The peptide mixtures of HLA-DRB1*0405 MAPEL induced an average of 28,000␣ cpm proliferation of PBL from an HLA-DRB1*0405-positive donor, but only an average of 8000␣ cpm proliferation of PBL from an HLA-DRB1*0101-positive donor. Conversely, the HLA-DRB1*0101-motif-oriented peptide mixtures induced an average of 20,000␣ cpm proliferation of PBL from an HLA-DRB1*0101-positive donor, and only 5000␣ cpm average proliferation of PBL from an HLA-DRB1*0405-positive donor. Thus, even a difference in one residue on the peptide between two HLA-DR allelic products was sufficient to cause drastic differences in PBL responses.
We also examined the proliferation of PBL from two HLA-DRB1*0405-positive donors and two HLA-DRB1*0901-positive donors to the nine sets of peptide mixtures for both alleles (Fig.␣ 3b) . The peptide mixtures of HLA-DRB1*0405 MAPEL induced an average of 27,000␣ cpm proliferation of PBL from two HLA-DRB1*0405-positive donors, but only an average of 4000␣ cpm in PBL from two HLA-DRB1*0901-positive donors. Conversely, the HLA-DRB1*0901-motif-oriented peptide mixtures induced an average of 38,000␣ cpm proliferation of PBL from two HLA-DRB1*0901-positive donors, and an average of 8000␣ cpm in PBL from two HLA-DRB1*0405-positive donors. These results indicated that each HLA-binding anchor (HLA natural ligand motif) plays a potentially important role in the formation of the antigenic repertoires recognized by adult peripheral T cells, and that the binding motif is indeed an important factor for proliferative sensitivity in the MAPEL design.
The detection of T cell epitopes of specific T cell lines by using the HLA-DRB1*0405 MAPEL We examined the proliferative responses to the HLA-DRB1*0405 MAPEL by seven T cell lines and seven T cell 
Influence of the HLA-binding motif on PBL proliferation
We further investigated the influence of the HLA-binding motif on PBL proliferation against library mixtures using zation for the HLA-DRB1*0405-binding motif (Fig.␣ 2) . Furthermore, peptide mixtures designed in consideration of the binding motifs for HLA-DRB1*0101 and HLA-DRB1*0901 showed reactivity only to PBL from donors with the respective alleles, suggesting that the association of certain autoimmune diseases with specific HLA genes may be related to the peptide motif of the HLA molecule. Thus, by limiting the peptides in the library to those which possess the binding motif for a given HLA molecule, it is possible to optimize a peptide library for the detection of epitopes that are predominant in the PBL of donors with a given HLA allele. This could be primarily due to the preferentially high binding affinities of library peptides to the targeted HLA molecule. Such specific analysis of the effects of the HLA-binding motif on T cell proliferation defines more accurately the peptide motif, and thus is useful for databaseoriented epitope prediction. The current MAPEL design exhibits increased sensitivity and separation, compared with comprehensive designs, allowing for the direct screening of unprimed T cell proliferative responses in adult PBL, in addition to the detection of epitopes for T cell lines and clones. However, reductions in the total number of tested peptides per mixture may reduce the comprehensiveness of the library. A truly optimized design would offer the maximized balance between resolution and sensitivity. Although any design utilizing mixtures of peptides to screen iteratively T cell activity is inherently biased toward the selection of highly promiscuous or cross-reactive T cell clones, for the investigation of T cell epitopes involved in autoimmune diseases (Barnaba and Sinigaglia1997) and graft-versus-host disease, where T cell cross-reaction and TCR promiscuity have been implicated as mechanisms of disease pathogenesis and causation, some bias towards cross-reactive clones may not adversely affect the usefulness of library approaches for the identification of T cell antigen specificities.
The major problem in the search for pathogenic autoimmunogens is the difficulty in obtaining autoreactive T cell clones from patients. While library methods can only identify "mimics" of actual antigenic peptides, these mimics can be used to culture T cells involved in disease and search for the actual target autoantigen of these T cells.
clones (two alloreactive T cell lines and six T cell clones specific to HLA-DRB1*08032, one PPD-specific T cell line and clone, 4 SCW-specific T cell lines), all derived from HLA-DRB1*0405-positive donors. The aim was to evaluate the ability of the MAPEL to resolve different epitope specificities by measuring the T cell proliferative response using L-DR4 as the antigen-presenting cell. Among these 14, four T cell lines and three T cell clones responded to at least one peptide mixture within the HLA-DRB1*0405 MAPEL (data not shown). Figure␣ 4 shows three typical cases of T cell line responses to the HLA-DRB1*0405 MAPEL. Nine of the 135 peptide mixtures induced strong proliferation, more than 15,000␣ cpm, of the HLA-DRB1*08032-specific and alloreactive T cell line from an HLA-DRB1*0405 homozygote; the background response was 500␣ cpm.
In contrast to this alloreactive T cell line, only one mixture from the MAPEL induced strong proliferation of the PPD-specific T cell line from an HLA-DRB1*0405 heterozygote, and another mixture from the MAPEL induced strong proliferation of the SCW-specific T cell line (Fig.␣ 4) . Although almost all peptide mixtures induced the proliferation of PBL from HLA-DRB1*0405-positive donors, only 1-9 mixtures induced the proliferation of each T cell line. This indicated that each residue of the peptide mixture was indeed important in distinguishing the activity of specific T cells in heterogeneous T cell populations.
Discussion
The present design of the peptide library utilized a subset of peptides that fit the binding motif for the target HLA molecule. The peptides were further divided into separate mixtures by assigning fixed, relatively unobtrusive amino acid residues (alanine, in this case) to two of the six putative TCR contact points and alternating these fixed positions in different mixtures to generate the library. The primary advantage of this design is that most peptides in the mixture are actually screened by T cells, as compared with "comprehensive" design, due to smaller numbers of peptide species in comparable mixtures. The strong and specific responses of T cell lines and clones of different antigenic specificities to separate mixtures in the present library indicated the successful separation of different antigenic repertoires by the present design (Fig.␣ 4) . This feature makes it possible to resolve the TCR specificity of T cell subpopulations within heterogeneous T cell populations such as PBL, or autoreactive T cells localized at the pathological sites of autoimmune diseases.
It can be estimated that at least one cell in 10 5 PBL was capable of cross-reacting with at least one individual peptide of the 729 peptide species of the mixture since 10 5 unprimed PBL in a microtiter well were able to respond to each combination of the 729 peptide species (Fig.␣ 1 ). This suggests a high level of antigenic promiscuity for T cells in PBL. Only PBL from HLA-DRB1*0405-positive donors responded to the HLA-DRB1*0405 library, indicating that the PBL responses to library mixtures were due to optimi-
